BIOMAT Database Logo BIOMAT Database Logo

The role of the integrin vitronectin receptor, alpha v beta 3 in melanoma metastasis. 1995

J Nip, and P Brodt
Department of Surgery, McGill University, Montreal, Quebec, Canada.

UI MeSH Term Description Entries
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012878 Skin Neoplasms Tumors or cancer of the SKIN. Cancer of Skin,Skin Cancer,Cancer of the Skin,Neoplasms, Skin,Cancer, Skin,Cancers, Skin,Neoplasm, Skin,Skin Cancers,Skin Neoplasm
D019030 Receptors, Vitronectin Receptors such as INTEGRIN ALPHAVBETA3 that bind VITRONECTIN with high affinity and play a role in cell migration. They also bind FIBRINOGEN; VON WILLEBRAND FACTOR; osteopontin; and THROMBOSPONDINS. Vitronectin Receptors

Related Publications

J Nip, and P Brodt
The role of the alpha v beta 3 integrin (vitronectin receptor) in platelet-melanoma interaction and metastasis.
June 1993, Nouvelle revue francaise d'hematologie,
J Nip, and P Brodt
The alpha v beta 3 integrin "vitronectin receptor".
May 1997, The international journal of biochemistry & cell biology,
J Nip, and P Brodt
The alpha v beta 5 integrin receptor regulates receptor-mediated endocytosis of vitronectin.
June 1993, The Journal of biological chemistry,
J Nip, and P Brodt
Urinary excretion of the vitronectin receptor (integrin alpha V beta 3) in patients with Fabry disease.
January 1999, Clinica chimica acta; international journal of clinical chemistry,
J Nip, and P Brodt
Role of the alpha v beta 3 integrin in human melanoma cell invasion.
March 1992, Proceedings of the National Academy of Sciences of the United States of America,
J Nip, and P Brodt
Vitronectin receptor alpha(V)beta(3) integrin antagonists: chemical and structural requirements for activity and selectivity.
December 2002, Mini reviews in medicinal chemistry,
J Nip, and P Brodt
Discovery of potent nonpeptide vitronectin receptor (alpha v beta 3) antagonists.
July 1997, Journal of medicinal chemistry,
J Nip, and P Brodt
Entry of coxsackievirus A9 into host cells: specific interactions with alpha v beta 3 integrin, the vitronectin receptor.
September 1994, Virology,
J Nip, and P Brodt
Integrin (alpha v beta 3)-ligand interaction. Identification of a heterodimeric RGD binding site on the vitronectin receptor.
February 1990, The Journal of biological chemistry,
J Nip, and P Brodt
Involvement of tumor cell integrin alpha v beta 3 in hematogenous metastasis of human melanoma cells.
January 2002, Clinical & experimental metastasis,
Copied contents to your clipboard!